BGI Genomics Co Ltd - Class A

SZSE:300676 (China)   Class A
Â¥ 37.89 (-1.92%) Jun 6
229.64
P/B:
1.58
Market Cap:
Â¥ 15.68B ($ 2.16B)
Enterprise V:
Â¥ 11.55B ($ 1.59B)
Volume:
2.52M
Avg Vol (2M):
2.72M
Volume:
2.52M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for BGI Genomics Co Ltd ( SZSE:300676 ) from 2017 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. BGI Genomics stock (SZSE:300676) PE ratio as of Jun 06 2024 is 229.64. More Details

BGI Genomics Co Ltd (SZSE:300676) PE Ratio (TTM) Chart

To

BGI Genomics Co Ltd (SZSE:300676) PE Ratio (TTM) Historical Data

Total 1199
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
BGI Genomics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 229.6 2024-03-28 249.5
2024-06-05 234.1 2024-03-27 181.2
2024-06-04 235.1 2024-03-26 185.9
2024-06-03 233.3 2024-03-25 186.7
2024-05-31 237.9 2024-03-22 193.1
2024-05-30 236.5 2024-03-21 198.9
2024-05-29 236.2 2024-03-20 203.4
2024-05-28 236.5 2024-03-19 198.0
2024-05-27 239.3 2024-03-18 199.0
2024-05-24 237.6 2024-03-15 191.8
2024-05-23 240.0 2024-03-14 192.0
2024-05-22 246.4 2024-03-13 192.6
2024-05-21 245.2 2024-03-12 194.6
2024-05-20 249.3 2024-03-11 191.3
2024-05-17 250.3 2024-03-08 187.5
2024-05-16 248.1 2024-03-07 186.6
2024-05-15 248.1 2024-03-06 195.1
2024-05-14 251.3 2024-03-05 197.6
2024-05-13 253.3 2024-03-04 200.0
2024-05-10 258.5 2024-03-01 195.7
2024-05-09 261.6 2024-02-29 195.7
2024-05-08 259.6 2024-02-28 194.8
2024-05-07 256.6 2024-02-27 199.7
2024-05-06 253.4 2024-02-26 195.1
2024-04-30 249.3 2024-02-23 194.4
2024-04-29 249.8 2024-02-22 194.8
2024-04-26 240.8 2024-02-21 194.7
2024-04-25 235.9 2024-02-20 195.3
2024-04-24 236.8 2024-02-19 196.2
2024-04-23 237.8 2024-02-08 199.0
2024-04-22 236.2 2024-02-07 199.7
2024-04-19 230.8 2024-02-06 183.0
2024-04-18 233.0 2024-02-05 165.5
2024-04-17 232.8 2024-02-02 162.2
2024-04-16 229.9 2024-02-01 167.7
2024-04-15 236.5 2024-01-31 165.8
2024-04-12 234.2 2024-01-30 174.1
2024-04-11 238.0 2024-01-29 179.0
2024-04-10 240.3 2024-01-26 183.6
2024-04-09 245.0 2024-01-25 189.3
2024-04-08 237.6 2024-01-24 182.7
2024-04-03 248.1 2024-01-23 179.2
2024-04-02 251.2 2024-01-22 175.7
2024-04-01 255.8 2024-01-19 185.0
2024-03-29 248.1 2024-01-18 185.6

BGI Genomics Co Ltd (SZSE:300676) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.